Stockreport

Lucid Diagnostics gets notice of allowance for patent underlying its esoguard esophageal DNA test [Seeking Alpha]

Lucid Diagnostics Inc.  (LUCD) 
PDF The notice is for a patent application covering its proprietary method of using methylation of the cyclin-A1 gene to help detect esophageal precancer and cancer. Sour [Read more]